Starting With Ibrutinib May Help Some Leukemia Patients Achieve Complete Response Starting With Ibrutinib May Help Some Leukemia Patients Achieve Complete Response

In patients with chronic lymphocytic leukemia (CLL), initial therapy with ibrutinib is among the factors that increase the likelihood of a complete response, according to pooled data from two trials.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news